Augurex Announces UKCA Authorization for SPINEstat™, Expanding Access to a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis to Great Britain
VANCOUVER, British Columbia--(BUSINESS WIRE)--Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that SPINEstat™ has received UK Conformity Assessed (UKCA) marking by the Medicines and Healthcare products Regulatory Agency (MHRA), authorizing the blood test for clinical use and listing it as an in vitro diagnostic (IVD) in Great Britain.
"By enabling earlier detection of this debilitating condition, SPINEstat™ empowers healthcare professionals to intervene sooner and improve outcomes for patients.'
Share
SPINEstat™ is a blood test that detects auto-antibodies to the 14-3-3eta protein and provides physicians with a new objective tool to assist in the diagnosis of axial spondyloarthritis (axSpA), a chronic inflammatory disease that commonly presents as persistent back pain. Symptoms often begin before the age of 45 and can lead to irreversible spinal fusion and reduced mobility if left untreated.
With a well-documented average delay of 7–10 years between the onset of symptoms and diagnosis, many patients with axSpA can endure years of back pain coupled with disease progression and disability. SPINEstat™ can help bridge this diagnostic gap by assisting physicians in differentiating axSpA from other forms of mechanical or chronic back pain.
'The MHRA authorization of SPINEstat™ represents a major step forward in improving the diagnostic pathway for axSpA in the UK,' said Neil Klompas, CEO of Augurex. 'As we grow our global footprint, this milestone reflects our commitment to expand access of advanced precision diagnostics for autoimmune diseases. By enabling earlier detection of this debilitating condition, SPINEstat™ empowers healthcare professionals to intervene sooner and improve outcomes for patients.'
With this UKCA authorization, Augurex continues its mission to improve autoimmune disease detection globally, equipping physicians with next-generation diagnostic tools that are evidence-based and clinically actionable.
About Augurex
Augurex is a commercial stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, allowing treatment options to be optimized and personalized for patients around the world. Augurex's lead diagnostic test, which detects the 14-3-3eta protein, available as JOINTstat® in Canada and Great Britain, is an important tool in the diagnosis and management of inflammatory diseases, including rheumatoid arthritis. The analyte-specific reagents to detect 14-3-3eta are available for purchase and use by U.S. clinical laboratories as a component of diagnostic tests developed by such laboratories. The Anti-14-3-3eta Multiplex ASRs, available as SPINEstat™ in Canada and Great Britain, expands Augurex's biomarker-informed diagnostic autoimmune solutions into axial spondyloarthritis, an autoimmune disease often misdiagnosed as low back pain, and which if untreated can lead to impaired spinal mobility and fusion of the vertebrae. Learn more about Augurex at www.augurex.com and follow us on Facebook, LinkedIn, and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Scientists use satellites to mimic a total solar eclipse in space
Two European satellites have successfully manufactured artificial solar eclipses by maintaining a precise formation in space. This innovative technique offers scientists extended periods of totality on demand. The European Space Agency unveiled images from these eclipses at the Paris Air Show on Monday. The pair of satellites, launched in late 2023, have been creating simulated solar eclipses since March, while orbiting thousands of miles above the Earth. The satellites fly 492 feet (150 meters) apart. One satellite blocks the sun, mimicking the moon's role in a natural solar eclipse. The other satellite then focuses its telescope on the corona, the sun's outer atmosphere, which appears as a halo of light. It's an intricate, prolonged dance requiring extreme precision by the cube-shaped spacecraft, less than 5 feet (1.5 meters) in size. Their flying accuracy needs to be within a mere millimeter, the thickness of a fingernail. This meticulous positioning is achieved autonomously through GPS navigation, star trackers, lasers and radio links. Dubbed Proba-3, the $210 million mission has generated 10 successful solar eclipses so far during the ongoing checkout phase. The longest eclipse lasted five hours, said the Royal Observatory of Belgium's Andrei Zhukov, the lead scientist for the orbiting corona-observing telescope. He and his team are aiming for a wondrous six hours of totality per eclipse once scientific observations begin. Scientists already are thrilled by the preliminary results that show the corona without the need for any special image processing, said Zhukov. "We almost couldn't believe our eyes,' Zhukov said in an email. 'This was the first try, and it worked. It was so incredible.' Zhukov anticipates an average of two solar eclipses per week being produced for a total of nearly 200 during the two-year mission, yielding more than 1,000 hours of totality. That will be a scientific bonanza since full solar eclipses produce just a few minutes of totality when the moon lines up perfectly between Earth and the sun — on average just once every 18 months. The sun continues to mystify scientists, especially its corona, which is hotter than the solar surface. Coronal mass ejections result in billions of tons of plasma and magnetic fields being hurled out into space. Geomagnetic storms can result, disrupting power and communication while lighting up the night sky with auroras in unexpected locales. While previous satellites have generated imitation solar eclipses — including the European Space Agency and NASA's Solar Orbiter and Soho observatory — the sun-blocking disk was always on the same spacecraft as the corona-observing telescope. What makes this mission unique, Zhukov said, is that the sun-shrouding disk and telescope are on two different satellites and therefore far apart. The distance between these two satellites will give scientists a better look at the part of the corona closest to the limb of the sun. "We are extremely satisfied by the quality of these images, and again this is really thanks to formation flying' with unprecedented accuracy, ESA's mission manager Damien Galano said from the Paris Air Show.
Yahoo
29 minutes ago
- Yahoo
Boveda's Precision Humidity Control Elevates Herbal Freshness in the New Crumblr Aerator
Boveda technology keeps herbs fresher longer in the innovative Crumblr aerator MINNETONKA, Minn., June 16, 2025--(BUSINESS WIRE)--Boveda, the global leader in precise, reliable 2-way humidity control, is proud to announce its technology is now featured in the Crumblr—a new, user-friendly herbal aerator, humidor, and storage system. The Crumblr is the first device of its kind offered by a third party to integrate Boveda's patented humidity control, ensuring that aerated herbs stay fresher, more potent, and better tasting for longer. With Boveda's 2-way humidity control technology at its core, the Crumblr offers a significant upgrade for anyone who values freshness and quality. Boveda's innovative technology automatically regulates humidity inside the Crumblr, protecting terpenes and extending shelf life. Once herbs are aerated and fluffed, they remain at their peak, preserved against overdrying or moisture damage. "Combining Boveda's 2-way humidity control with the Crumblr is a game-changer in the world of precision grinding," said Boveda's Wholesale Direct Accounts Manager, Mike Kanowitz. "We are delighted that Crumblr recognized the game-changing technology that Boveda delivers by incorporating our product into Crumblr's advanced design." "For rapidly chewing through any quantities of biomass while keeping cannabis fresh with Boveda's unique humidity control, there is no better solution available," Jake Kuczeruk, Budist. "The unique hand-crank mechanism of the Crumblr is revolutionary for medical cannabis users who need convenient, high-quality cannabis, especially those struggling with arthritis." Boveda's inclusion in the Crumblr means users benefit from the same gold-standard humidity control trusted by professionals worldwide. Herbs remain fluffy, aromatic, and potent, with terpenes and flavors preserved for an exceptional experience. Follow this link to see Boveda and the Crumblr in action: ### About Boveda Inc.: Boveda Inc. is the global leader in 2-way humidity control. The brand's suite of products preserve moisture-sensitive items, including cigars, cannabis, medical devices, guitars, and more. Headquartered in Minnetonka, Minnesota, Boveda invented and patented the Original Terpene Shield™, which protects dried cannabis in storage, transport, and packaging. Made with all-natural salts and purified water, Boveda's ready-to-use packs allow moisture to pass in and out as necessary through a semipermeable vapor-phase reverse osmosis membrane. The purified water creates a powerful terpene shield that protects precious trichomes by preventing evaporation and preserving terpenes and other volatile compounds. Innovative companies ensure an exceptional consumer experience by using Boveda to maintain the quality, consistency, and freshness of their moisture-sensitive products. For more information, visit or call 952-745-2900. About Crumblr: Crumblr by Project Epoch LLC is the world's first 3-in-1 humidor, storage container, and aerating grinder. It is designed to preserve the natural quality of herbs while delivering a consistent and effective grind. The device uses a patent-pending dual-blade system with built-in humidity control to gently fluff the material instead of crushing it. Tests show improved burn consistency and product density. Crumblr is founded by a diverse team and is certified as an SBA 8(a) business. It is built for quality, inclusion, and broad use across herbal, culinary, and wellness markets. For more information, visit View source version on Contacts Boveda Inc. Rachel AlbertsonBoveda, Inc.(605) Crumblr media@
Yahoo
29 minutes ago
- Yahoo
InContext Solutions and r4 Technologies Partner to Deliver Groundbreaking Hyperlocal Offering
Joint AI technology provides assortment and arrangement as an AI-powered Service CHICAGO, June 16, 2025 /PRNewswire/ -- InContext Solutions, the global leader in 3D simulation software for retail, and r4 Technologies, the pioneer of cross-enterprise AI, today announce their partnership to create a brand-new hyperlocal merchandising SaaS AI offering for optimized assortment and arrangement at the store level. "Traditionally, the approach to localized assortment, arrangement, and promotion execution haven't allowed for accuracy or scalability," said Rich Scamehorn, Chief Data Officer and Managing Director, AI at InContext Solutions. "InContext is thrilled to join forces with r4 to enable a cost-effective pathway to competitive advantage through operational precision." The combined venture of r4's revolutionary XEM® (Cross-Enterprise Management) AI software with InContext's behavioral-data-driven approach to arrangement optimization positions brands to transform their approach to category management at a store-level, with greater precision, faster, at a lower total cost. "Fragmentation of consumer markets and proliferation of niche products have made store-level assortment management a competitive requirement," stated David Bradley, Vice-President of Solutions at r4, "We're excited about our partnership with InContext and to incorporate our New AI technology to help grow revenue and boost efficiency overall." Additional Resources: To learn more about InContext Solutions, please visit To learn more about r4, please visit About InContext SolutionsInContext is the global leader in 3D visual retail merchandising technology. Powered by ShopperMX, our virtual visualization platform for shopper insights, visual merchandising, retail execution and virtual commerce, empowers teams to visualize first in a digital twin of the retail store to maximize ROI and mitigate risk when bringing new ideas to market. About r4 Technologies, Inc.r4 Technologies, Inc, created in 2013 by the founders of priceline, is the pioneer of Cross-Enterprise AI. Organizations across commercial and public sectors deploy r4's AI technology platform to put Decision Intelligence in the hands of business users to drive action. The company is based in Ridgefield, CT with operations in New York City, Toronto, Dublin, Austin, Knoxville, Manhattan, KS and Lawton, OK. InContext Solutions Public Relations Contact:Gina Joseph, Director of r4 Public Relations Contact:Matthew Marchak, Head of Brandmmarchak@ View original content to download multimedia: SOURCE InContext Solutions Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
